Advertisement

Precipitation Technologies for Nanoparticle Production

  • Jasmine M. Rowe
  • Keith P. Johnston
Chapter
Part of the AAPS Advances in the Pharmaceutical Sciences Series book series (AAPS, volume 3)

Abstract

Precipitation technologies have been widely studied for nanoparticle production because they provide more control over particle size, shape, and morphology as compared to mechanical processes, such as milling and homogenization. Several precipitation processes are discussed in this chapter, with special attention to experimental parameters and typical particle attributes. The chapter also touches on novel nanoparticle recovery techniques that may be coupled with precipitation processes to enable these precipitation technologies to be scaled for commercial applications.

Keywords

Particle Growth Drug Particle Submicron Particle Final Particle Size Nozzle Design 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Albano AA, Phuapradit W, Sandhu HK, Shah NH (2002) Stable complexes of poorly soluble compounds in ionic polymers US 6,350,786Google Scholar
  2. Bakhbakhi Y, Rohani S, Charpentier PA (2005) Micronization of phenanthrene using the gas antisolvent process: part 2. Theoretical study. Ind Eng Chem Res 44(19):7345–7351Google Scholar
  3. Baldyga J, Czarnocki R, Shefeunov BY, Smith KB (2010) Particle formation in supercritical fluids – scale-up problem. Chem Eng Res Des 88:331–341Google Scholar
  4. Blankschtein D, Thurston GM, Benedek GB (1986) Phenomenological theory of equilibrium thermodynamic properties and phase separation of micellar solutions. J Chem Phys 85(12):7268–88Google Scholar
  5. Bristow S, Shekunov T, Shekunov BY, York P (2001) Analysis of the supersaturation and precipitation process with supercritical CO2. J Supercrit Fluids 21(3):257–271Google Scholar
  6. Bustami R, Chan H-K, Dehghani F, Foster N (2000) In Generation of protein microparticles using high pressure modified carbon dioxide, International Symposium on Supercritical Fluids, Atlanta, GAGoogle Scholar
  7. Carl LY (1999) Chemical properties handbook. McGraw-Hill, New York, NYGoogle Scholar
  8. Chan H-K, Chew NYK (2003) Novel alternative methods for the delivery of drugs for the treatment of asthma. Adv Drug Deliv Rev 55(7):793–805PubMedGoogle Scholar
  9. Chang SA, Gray DG (1978) The surface tension of aqueous hydroxypropyl cellulose solutions. J Colloid Interface Sci 67:255–265Google Scholar
  10. Charoenchaitrakool M, Dehghani F, Foster NR, Chan HK (2000) Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind Eng Chem Res 39(12):4794–4802Google Scholar
  11. Chattopadhyay P, Gupta RB (2001a) Production of griseofulvin nanoparticles using supercritical CO2 antisolvent with enhanced mass transfer. Int J Pharm 228(1–2):19–31PubMedGoogle Scholar
  12. Chattopadhyay P, Gupta RB (2001b) Production of antibiotic nanoparticles using supercritical CO2 as antisolvent with enhanced mass transfer. Ind Eng Chem Res 40(16):3530–3539Google Scholar
  13. Chattopadhyay P, Gupta RB (2002) Protein nanoparticles formation by supercritical antisolvent with enhanced mass transfer. AICHE J 48(2):235–244Google Scholar
  14. Chen X, Young TJ, Sarkari M, Williams RO, Johnston KP (2002) Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int J Pharm 242(1–2):3–14PubMedGoogle Scholar
  15. Chen X, Vaughn JM, Yacaman MJ, Williams RO, Johnston KP III (2004a) Rapid dissolution of high-potency danazol particles produced by evaporative precipitation into aqueous solution. J Pharm Sci 93(7):1867–1878PubMedGoogle Scholar
  16. Chen X, Ill Benhayoune Z, Williams RO, Johnston KP (2004b) Rapid dissolution of high potency itraconazole particles produced by evaporative precipitation into aqueous solution. J Drug Deliv Sci Technol 14(4):299–304Google Scholar
  17. Chen X, Lo CY-L, Sarkari M, Williams RO, Johnston KP III (2006) Ketoprofen nanoparticle gels formed by evaporative precipitation into aqueous solution. AICHE J 52(7):2428–2435Google Scholar
  18. Chen XX, Matteucci ME, Lo CY, Johnston KP, Williams RO (2009) Flocculation of polymer stabilized nanocrystal suspensions to produce redispersible powders. Drug Dev Ind Pharm 35(3):283–296PubMedGoogle Scholar
  19. Chiou H, Chan H-K, Heng D, Prud’homme RK, Raper JA (2008a) A novel production method for inhalable cyclosporine A powders by confined liquid impinging jet precipitation. J Aerosol Sci 39(6):500–509Google Scholar
  20. Chiou H, Chan H-K, Prud’homme RK, Raper JA (2008b) Evaluation on the use of confined liquid impinging jets for the synthesis of nanodrug particles. Drug Dev Ind Pharm 34(1):59–64PubMedGoogle Scholar
  21. Crison JR (2000) Biopharmaceutical aspects of water-insoluble drugs for oral drug delivery. In: LIU R (ed) Water-insoluble drug formulation. CRC Press, Boca Raton, FLGoogle Scholar
  22. Daniels R, Barta A (1994) Pharmacopoeial cellulose ethers as oil-in-water emulsifiers I: interfacial properties. Eur J Pharm Biopharm 40:128–133Google Scholar
  23. de la Fuente Badilla JC, Peters CJ, de Swaan Arons J (2000) Volume expansion in relation to the gas-antisolvent process. J Supercrit Fluids 17(1):13–23Google Scholar
  24. de la Fuente JC, Shariati A, Peters CJ (2004) On the selection of optimum thermodynamic conditions for the GAS process. J Supercrit Fluids 32(1–3):55–61Google Scholar
  25. Dearn AR (1994) Atovaquone pharmaceutical compositions. WO 9414426, 23 Dec 1993Google Scholar
  26. Debenedetti PG (1990) Homogeneous nucleation in supercritical fluids. AICHE J 36(9):1289–98Google Scholar
  27. Debenedetti PG, Tom JW, Kwauk X, Yeo SD (1993) Rapid expansion of supercritical solutions (RESS): fundamentals and applications. Fluid Phase Equilibr 82:311–21Google Scholar
  28. Dodds S, Wood JA, Charpentier PA (2007) Modeling of the gas-antisolvent (GAS) process for crystallization of beclomethasone dipropionate using carbon dioxide. Ind Eng Chem Res 46:8009–8017Google Scholar
  29. Domingo C, Berends E, van Rosmalen GM (1997) Precipitation of ultrafine organic crystals from the rapid expansion of supercritical solutions over a capillary and a frit nozzle. J Supercrit Fluids 10(1):39–55Google Scholar
  30. Dong Y, Ng WK, Shen S, Kim S, Tan RBH (2009) Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. Int J Pharm 375(1–2):84–88PubMedGoogle Scholar
  31. Dong Y, Ng WK, Hu J, Shen S, Tan RBH (2010) A continuous and highly effective static mixing process for antisolvent precipitation of nanoparticles of poorly water-soluble drugs. Int J Pharm 386(1–2):256–261PubMedGoogle Scholar
  32. Elvassore N, Parton T, Bertucco A, Di Noto V (2003) Kinetics of particle formation in the gas antisolvent precipitation process. AICHE J 49(4):859–868Google Scholar
  33. Elvassore N, Cozzi F, Bertucco A (2004) Mass transport modeling in a gas antisolvent process. Ind Eng Chem Res 43(16):4935–4943Google Scholar
  34. Engstrom JD, Simpson DT, Cloonan C, Lai ES, Williams RO III, Kitto GB, Johnston KP (2007) Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen. Eur J Pharm Biopharm 65(2):163–174PubMedGoogle Scholar
  35. Engstrom JD, Lai ES, Ludher B, Chen B, Milner TE, Kitto GB, Williams RO III, Johnston KP (2008) Formation of stable submicron protein particles by thin film freezing. Pharm Res 25(6):1334–1336PubMedGoogle Scholar
  36. Falk R, Randolph TW, Meyer JD, Kelly RM, Manning MC (1997) Controlled release of ionic compounds from poly(L-lactide) microspheres produced by precipitation with a compressed antisolvent. J Control Release 44(1):77–85Google Scholar
  37. Flaherty KT, Puzanov I, Kim KB, Ribas A, McArthur GA, Sosman JA, O’Dwyer PJ, Lee RJ, Grippo JF, Nolop K, Chapman PB (2010) Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363(9):809–819PubMedGoogle Scholar
  38. Franklin RK, Edwards JR, Chernyak Y, Gould RD, Henon F, Carbonell RG (2001) Formation of perfluoropolyether coatings by the rapid expansion of supercritical solutions (RESS) process. Part 2: numerical modeling. Ind Eng Chem Res 40(26):6127–6139Google Scholar
  39. Fusaro F, Mazzotti M, Muhrer G (2004) Gas antisolvent recrystallization of paracetamol from acetone using compressed carbon dioxide as antisolvent. Cryst Growth Des 4(5):881–889Google Scholar
  40. Fusaro F, Haenchen M, Mazzotti M, Muhrer G, Subramaniam B (2005) Dense gas antisolvent precipitation: a comparative investigation of the GAS and PCA techniques. Ind Eng Chem Res 44(5):1502–1509Google Scholar
  41. Gardner CR, Walsh CT, Almarsson O (2004) Drugs as materials: valuing physical form in drug discovery. Nat Rev Drug Discov 3(11):926–934PubMedGoogle Scholar
  42. Gassmann P, List M, Schweitzer A, Sucker H (1994) Hydrosols - alternatives for the parenteral application of poorly water-soluble drugs. Eur J Pharm Biopharm 40(2):64–72Google Scholar
  43. Gupta RB (2006) Nanoparticle technology for drug delivery, vol 53, 1st edn. Taylor & Francis, New York, pp 53–84Google Scholar
  44. Hanna M, York P (1998) Method  +  apparatus for the formation of particles. WO 9836825, February 20, 1998Google Scholar
  45. Heimenz PC, Rajagopalan R (1997) Principles of colloid and surface chemistry. Marcel Dekker, New York, NYGoogle Scholar
  46. Helfgen B, Turk M, Schaber K (2003) Hydrodynamic and aerosol modelling of the rapid expansion of supercritical solutions (RESS-process). J Supercrit Fluids 26(3):225–242Google Scholar
  47. Hitt JE, Tucker CJ, Evans JC, Curtis CA, Svenson S (2003) Process to precipitate drug particles. US 20030049323, 08/27/2002Google Scholar
  48. Hitt JE, Rogers TL, Gillespie IB, Scherzer BD, Garcia PC, Beck NS, Tucker CJ, Young TJ, Hayes DA, Williams RO III, Johnston KP, McConville JT, Peters JI, Talbert R, Burgess D (2006) Enhanced delivery of pharmaceutical compositions to treat life threatening infections. WO 2006026502, 08/26/2005Google Scholar
  49. Hu J, Johnston KP, Williams RO III (2004) Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs. Drug Dev Ind Pharm 30(3):233–245PubMedGoogle Scholar
  50. Hu J, Ng W-K, Dong Y-C, Shen S-C, Tan RBH (2011) Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm 404(1–2):198–204PubMedGoogle Scholar
  51. Jacobs C, Kayser O, Muller RH (2000) Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm 196:161–164PubMedGoogle Scholar
  52. Jarmer DJ, Lengsfeld CS, Randolph TW (2003) Manipulation of particle size distribution of poly(l-lactic acid) nanoparticles with a jet-swirl nozzle during precipitation with a compressed antisolvent. J Supercrit Fluids 27(3):317–336Google Scholar
  53. Jarmer DJ, Lengsfeld CS, Randolph TW (2004) Nucleation and growth rates of poly(L-lactic acid) microparticles during precipitation with a compressed-fluid antisolvent. Langmuir 20(17):7254–7264PubMedGoogle Scholar
  54. Jarmer DJ, Lengsfeld CS, Randolph TW (2006) Scale-up criteria for an injector with a confined mixing chamber during precipitation with a compressed-fluid antisolvent. J Supercrit Fluids 37(2):242–253Google Scholar
  55. Johnson BK, Prud’homme RK (2003a) Flash nanoprecipitation of organic actives and block copolymers using a confined impinging jets mixer. Aust J Chem 56(10):1021–1024Google Scholar
  56. Johnson BK, Prud’homme RK (2003b) Chemical processing and micromixing in confined impinging, jets. AIChE J 49(9):2264–2282Google Scholar
  57. Johnson BK, Prud’homme RK (2003c) Mechanism for rapid self-assembly of block copolymer nanoparticles. Phys Rev Lett 91(11):118302/1–118302/4Google Scholar
  58. Johnson BK, Saad W, Prud’homme RK (2006) Nanoprecipitation of pharmaceuticals using mixing and block copolymer stabilization. ACS Sym Ser 924:278–291; Polymeric Drug Delivery IIGoogle Scholar
  59. Jouyban A, Rehman M, Shekunov BY, Chan H-K, Clark BJ, York P (2002) Solubility prediction in supercritical CO2 using minimum number of experiments. J Pharm Sci 91(5):1287–1295PubMedGoogle Scholar
  60. Kayrak D, Akman U, Hortaçsu Ö (2003) Micronization of Ibuprofen by RESS. J Supercrit Fluids 26(1):17–31Google Scholar
  61. Keck CM, Mueller RH (2006) Drug nanocrystals of poorly soluble drugs produced by high pressure homogenization. Eur J Pharm Biopharm 62(1):3–16PubMedGoogle Scholar
  62. Kipp JE (2004) The role of solid nanoparticle technology in the parenteral delivery of poorly water-soluble drugs. Int J Pharm 284(1–2):109–122PubMedGoogle Scholar
  63. Ksibi H, Subra P, Garrabos Y (1995) Formation of fine powdersof caffeine by RESS. Adv Powder Technol 6(1):25–33Google Scholar
  64. Larson RG (1999) The structure and rheology of complex fluids. Oxford University Press, New York, NYGoogle Scholar
  65. Lengsfeld CS, Delplanque JP, Barocas VH, Randolph TW (2000) Mechanism governing microparticle morphology during precipitation by a compressed antisolvent: atomization vs nucleation and growth. J Phys Chem B 104(12):2725–2735Google Scholar
  66. Li J, Rodrigues M, Paiva A, Matos HA, Gomes de Azevedo E (2005) Modeling of the PGSS process by crystallization and atomization. AIChE J 51(8):2343–2357Google Scholar
  67. Limayem I, Charcosset C, Fessi H (2004) Purification of nanoparticle suspensions by a concentration/diafiltration process. Sep Purif Technol 38:1–9Google Scholar
  68. Lin C, Muhrer G, Mazzotti M, Subramaniam B (2003) Vapor-liquid mass transfer during gas antisolvent recrystallization: modeling and experiments. Ind Eng Chem Res 42(10):2171–2182Google Scholar
  69. Lipinski CA (2001) Avoiding investment in doomed drugs. Is poor solubility an industry wide problem? Curr Drug Discov 17–19Google Scholar
  70. Lipinski C (2002) Poor aqueous solubility- an industry wide problem in drug discovery. Am Pharm Rev 5:82–85Google Scholar
  71. Liu G-T, Nagahama K (1996) Application of rapid expansion of supercritical solutions in the crystallization separation. Ind Eng Chem Res 35:4626–4634Google Scholar
  72. Liu Y, Cheng C, Liu Y, Prud’homme RK, Fox RO (2008) Mixing in a multi-inlet vortex mixer (MIVM) for flash nano-precipitation. Chem Eng Sci 63(11):2829–2842Google Scholar
  73. Liversidge GG, Cundy KC (1995) Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 125(1):91–7Google Scholar
  74. Liversidge EM, Liversidge GG, Cooper ER (2003) Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci 18:113–120PubMedGoogle Scholar
  75. Maa Y-F, Nguyen P-A, Sweeney T, Shire SJ, Hsu CC (1999) Protein inhalation powders: spray drying vs spray freeze drying. Pharm Res 16(2):249–254PubMedGoogle Scholar
  76. Martin A, Cocero MJ (2004) Numerical modeling of jet hydrodynamics, mass transfer, and crystallization kinetics in the supercritical antisolvent (SAS) process. J Supercrit Fluids 32(1–3):203–219Google Scholar
  77. Martin A, Cocero MJ (2008) Micronization processes with supercritical fluids: fundamentals and mechanisms. Adv Drug Deliv Rev 60(3):339–350PubMedGoogle Scholar
  78. Martin A, Bouchard A, Hofland GW, Witkamp GJ, Cocero MJ (2007) Mathematical modeling of the mass transfer from aqueous solutions in a supercritical fluid during particle formation. J Supercrit Fluids 41(1):126–137Google Scholar
  79. Martin A, Pham H, Kilzer A, Kareth S, Weidner E (2010) Micronization of polyethylene glycol by PGSS (particles from gas saturated solutions)-drying of aqueous solutions. Chem Eng Process 49:1259–1266Google Scholar
  80. Matteucci ME, Hotze MA, Johnston KP, Williams RO III (2006) Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir 22(21):8951–8959PubMedGoogle Scholar
  81. Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO, Johnston KP (2007) Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm 4(5):782–793PubMedGoogle Scholar
  82. Matteucci ME, Paguio JC, Miller MA, Williams RO, Johnston KP III (2008) Flocculated amorphous nanoparticles for highly supersaturated solutions. Pharm Res 25(11):2477–2487PubMedGoogle Scholar
  83. Matteucci ME, Paguio JC, Miller MA III, Williams RO, Johnston KP (2009) Highly supersaturated solutions from dissolution of amorphous itraconazole microparticles at pH 6.8. Mol Pharm 6(2):375–385PubMedGoogle Scholar
  84. Mendez-Santiago J, Teja AS (1999) The solubility of solids in supercritical fluids. Fluid Phase Equilibr 158–160:501–510Google Scholar
  85. Miller MA, DiNunzio J, Matteucci ME, Ludher BS III, Williams RO, Johnston KP. Flocculated amorphous itraconazole nanoparticles for enhanced in vitro supersaturation and in vivo bioavailability (Drug Development and Industrial Pharmacy. In press.)Google Scholar
  86. Mueller M, Meier U, Kessler A, Mazzotti M (2000) Experimental study of the effect of process parameters in the recrystallization of an organic compound using compressed carbon dioxide as antisolvent. Ind Eng Chem Res 39(7):2260–2268Google Scholar
  87. Muhrer G, Mazzotti M (2003) Precipitation of lysozyme nanoparticles from dimethyl sulfoxide using carbon dioxide as antisolvent. Biotechnol Prog 19(2):549–556PubMedGoogle Scholar
  88. Muhrer G, Lin C, Mazzotti M (2002) Modeling the gas antisolvent recrystallization process. Ind Eng Chem Res 41(15):3566–3579Google Scholar
  89. Muhrer G, Mazzotti M, Muller M (2003) Gas antisolvent recrystallization of an organic compound. Tailoring product PSD and scaling-up. J Supercrit Fluids 27(2):195–203Google Scholar
  90. Muller RH, Bohm BHL (1997) Colloidal drug carriers expert meeting, 3rd meeting, Berlin, Germany, May 29–31, 1997. In: Mueller RH, Benita S, Boehm BHL (eds) Nanosuspensions. Medpharm Scientific, Berlin, pp 149–174Google Scholar
  91. Muller RH, Jacobs C, Kayser O (2001) Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47(1):3–19PubMedGoogle Scholar
  92. Napper DH (1983) Polymeric stabilization of colloidal dispersions. Academic Press, New York, NYGoogle Scholar
  93. Nguyen XC, Herberger JD, Burke PA (2004) Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa. Pharm Res 21(3):507–514PubMedGoogle Scholar
  94. Noyes AA, Whitney WR (1897) The rate of solution of solid substances in their own solutions. J Am Chem Soc 19:930–934Google Scholar
  95. Okamoto H, Danjo K (2008) Application of supercritical fluid to preparation of powders of high-molecular weight drugs for inhalation. Adv Drug Deliv Rev 60(3):433–446PubMedGoogle Scholar
  96. Overhoff KA, Engstrom JD, Chen B, Scherzer BD, Milner TE, Johnston KP, Williams RO (2007a) Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs. Eur J Pharm Biopharm 65(1):57–67PubMedGoogle Scholar
  97. Overhoff KA, Moreno A, Miller DA, Johnston KP, Williams RO (2007b) Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing. Int J Pharm 336(1):122–132PubMedGoogle Scholar
  98. Overhoff KA, Johnston KP, Tam J, Engstrom J, Williams RO III (2009) Use of thin film freezing to enable drug delivery: a review. J Drug Deliv Sci Technol 19(2):89–98Google Scholar
  99. Padrela L, Rodrigues MA, Velaga SP, Matos HA, de Azevedo EG (2009) Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. Eur J Pharm Sci 38(1):9–17PubMedGoogle Scholar
  100. Pandit N, Trygstad T, Croy S, Bohorquez M, Koch C (2000) Effect of salts on the micellization, clouding, and solubilization behavior of pluronic F127 solutions. J Colloid Interface Sci 222:213–220PubMedGoogle Scholar
  101. Pang P, Englezos P (2002) Phase separation of polyethylene oxide (PEO)-water solution and its relationship to the flocculating capability of the PEO. Fluid Phase Equilibr 194–197:1059–1066Google Scholar
  102. Pathak P, Meziani MJ, Desai T, Sun Y-P (2004) Nanosizing drug particles in supercritical fluid processing. J Am Chem Soc 126(35):10842–10843PubMedGoogle Scholar
  103. Pathak P, Meziani MJ, Desai T, Sun Y-P (2006) Formation and stabilization of ibuprofen nanoparticles in supercritical fluid processing. J Supercrit Fluids 37(3):279–286Google Scholar
  104. Pathak P, Prasad GL, Meziani MJ, Joudeh AA, Sun Y-P (2007) Nanosized paclitaxel particles from supercritical carbon dioxide processing and their biological evaluation. Langmuir 23(5):2674–2679PubMedGoogle Scholar
  105. PerezdeDiego Y, Wubbolts FE, Jansens PJ (2006) Modelling mass transfer in the PCA process using the Maxwell–Stefan approach. J Supercrit Fluids 37(1):53–62Google Scholar
  106. Perrut M, Jung J, Leboeuf F (2005) Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes: part I: Micronization of neat particles. Int J Pharm 288(1):3–10PubMedGoogle Scholar
  107. Pratsinis SE (1988) Simultaneous nucleation, condensation, and coagulation in aerosol reactors. J Colloid Interface Sci 124(2):416–27Google Scholar
  108. Rabinow BE (2004) Nanosuspensions in drug delivery. Nat Rev Drug Discov 3(9):785–796PubMedGoogle Scholar
  109. Rasenack N, Muller BW (2002) Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs. Pharm Res 19(12):1894–1900PubMedGoogle Scholar
  110. Reverchon E, Della Porta G (1999) Production of antibiotic micro- and nano-particles by supercritical antisolvent precipitation. Powder Technol 106(1–2):23–29Google Scholar
  111. Reverchon E, Pallado P (1996) Hydrodynamic modeling of the RESS process. J Supercrit Fluids 9(4):216–221Google Scholar
  112. Reverchon E, Donsi G, Gorgoglione D (1993) Salicylic acid solubilization in supercritical CO2 and its micronization by RESS. J Supercrit Fluids 6(4):241–8Google Scholar
  113. Reverchon E, Della Porta G, Falivene MG (2000) Process parameters and morphology in amoxicillin micro and submicro particles generation by supercritical antisolvent precipitation. J Supercrit Fluids 17(3):239–248Google Scholar
  114. Reverchon E, Caputo G, De Marco I (2003a) Role of phase behavior and atomization in the supercritical antisolvent precipitation. Ind Eng Chem Res 42(25):6406–6414Google Scholar
  115. Reverchon E, De Marco I, Caputo G, Della Porta G (2003b) Pilot scale micronization of amoxicillin by supercritical antisolvent precipitation. J Supercrit Fluids 26(1):1–7Google Scholar
  116. Reverchon E, De Marco I, Torino E (2007) Nanoparticles production by supercritical antisolvent precipitation: a general interpretation. J Supercrit Fluids 43(1):126–138Google Scholar
  117. Reverchon E, Torino E, Dowy S, Braeuer A, Leipertz A (2010) Interactions of phase equilibria, jet fluid dynamics and mass transfer during supercritical antisolvent micronization. Chem Eng J 156:446–458Google Scholar
  118. Rodrigues M, Peiriço N, Matos H, Gomes de Azevedo E, Lobato MR, Almeida AJ (2004) Microcomposites theophylline/hydrogenated palm oil from a PGSS process for controlled drug delivery systems. J Supercrit Fluids 29(1–2):175–184Google Scholar
  119. Rodrigues MA, Li J, Padrela L, Almeida A, Matos HA, de Azevedo EG (2009) Anti-solvent effect in the production of lysozyme nanoparticles by supercritical fluid-assisted atomization processes. J Supercrit Fluids 48(3):253–260Google Scholar
  120. Rogers TL, Johnston KP, Williams RO III (2001a) Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies. Drug Dev Ind Pharm 27(10):1003–1015PubMedGoogle Scholar
  121. Rogers TL, Johnston KP, Williams RO III (2001b) Solution-based particle formation of pharmaceutical powders by supercritical or compressed fluid CO2 and cryogenic spray-freezing technologies. Drug Dev Ind Pharm 27(10):1003–1015PubMedGoogle Scholar
  122. Rogers TL, Gillespie IB, Hitt JE, Fransen KL, Crowl CA, Tucker CJ, Kupperblatt GB, Becker JN, Wilson DL, Todd C, Broomall CF, Evans JC, Elder EJ (2004) Development and characterization of a scalable controlled precipitation process to enhance the dissolution of poorly water-soluble drugs. Pharm Res 21(11):2048–2057PubMedGoogle Scholar
  123. Sarkari M, Brown J, Chen X, Swinnea S, Williams RO, Johnston KP (2002) Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm 243(1–2):17–31PubMedGoogle Scholar
  124. Sekhon BS (2010) Supercritical fluid technology: an overview of pharmaceutical applications. Int J PharmTechnol Res 2(1):810–826Google Scholar
  125. Shah N, Sandhu H, Phuapradit W, Lyer R, Albano A, Desai D, Choi D, Tang K, Tian H, Chokshi H, Go Z, Malick W, Radinov R, Shankar A, Wolff S, Mair H (2010) Solid complexes with ionic polymers. Pharm Technol 32(12):46–47Google Scholar
  126. Shariati A, Peters CJ (2002) Measurements and modeling of the phase behavior of ternary systems of interest for the GAS process: I. The system carbon dioxide + 1-propanol + salicylic acid. J Supercrit Fluids 23(3):195–208Google Scholar
  127. Shekunov BY, Hanna M, York P (1999) Crystallization process in turbulent supercritical flows. J Crystal Growth 198/199(Pt. 2):1345–1351Google Scholar
  128. Shoyele SA, Cawthorne S (2006) Particle engineering techniques for inhaled biopharmaceuticals. Adv Drug Deliv Rev 58(9–10):1009–1029PubMedGoogle Scholar
  129. Sinswat P, Gao X, Yacaman MJ, Williams RO, Johnston KP (2005) Stabilizer choice for rapid ­dissolving high potency itraconazole particles formed by evaporative precipitation into ­aqueous solution. Int J Pharm 302(1–2):113–124PubMedGoogle Scholar
  130. Sinswat P, Matteucci ME, Johnston KP, Williams RO III (2007) Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation. J Biomed Nanotechnol 3(1):18–27Google Scholar
  131. Sohnel O, Garside J (1992) Precipitation: basic principles and industrial applications. Butterworth-Heinemann, Newton, MAGoogle Scholar
  132. Sporanox Package Insert (Janssen Pharmaceutica Products, L.P.)Google Scholar
  133. Subramaniam B, Rajewski RA, Snavely K (1997) Pharmaceutical processing with supercritical carbon dioxide. J Pharm Sci 86(8):885–890PubMedGoogle Scholar
  134. Tam JM, McConville JT, Williams RO, Johnston KP III (2008) Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution. J Pharm Sci 97(11):4915–33PubMedGoogle Scholar
  135. Thakur R, Gupta RB (2005) Rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process: formation of griseofulvin nanoparticles. Ind Eng Chem Res 44(19):7380–7387Google Scholar
  136. Thakur R, Gupta RB (2006a) Rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process: formation of 2-aminobenzoic acid nanoparticle. J Supercrit Fluids 37(3):307–315Google Scholar
  137. Thakur R, Gupta RB (2006b) Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process. Int J Pharm 308(1–2):190–199PubMedGoogle Scholar
  138. Thote AJ, Gupta RB (2005) Formation of nanoparticles of a hydrophilic drug using supercritical carbon dioxide and microencapsulation for sustained release. Nanomedicine 1(1):85–90PubMedGoogle Scholar
  139. Torino E, Marco ID, Reverchon E (2010) Organic nanoparticles recovery in supercritical antisolvent precipitation. J Supercrit Fluids 55:300–306Google Scholar
  140. Turk M (2000) Influence of thermodynamic behaviour and solute properties on homogeneous nucleation in supercritical solutions. J Supercrit Fluids 18(3):169–184Google Scholar
  141. Turk M (2009) Manufacture of submicron drug particles with enhanced dissolution behaviour by rapid expansion processes. J Supercrit Fluids 47(3):537–545Google Scholar
  142. Turk M, Bolten D (2010) Formation of submicron poorly water-soluble drugs by rapid expansion of supercritical solution (RESS): results for naproxen. J Supercrit Fluids 55:778–785Google Scholar
  143. Turk M, Lietzow R (2008) Formation and stabilization of submicron particles via rapid expansion processes. J Supercrit Fluids 45:346–355Google Scholar
  144. Turk M, Hils P, Helfgen B, Schaber K, Martin HJ, Wahl MA (2002) Micronization of pharmaceutical substances by the rapid expansion of supercritical solutions (RESS): a promising method to improve bioavailability of poorly soluble pharmaceutical agents. J Supercrit Fluids 22(1):75–84Google Scholar
  145. Vaughn JM, Gao X, Yacaman M-J, Johnston KP, Williams RO (2005) Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques. Eur J Pharm Biopharm 60(1):81–89PubMedGoogle Scholar
  146. Weber M, Thies M (2002) Understanding the RESS process. In: Sun Y-P (ed) Supercritical fluid technology in materials science and engineering. Marcel Dekker, New York, pp 387–437Google Scholar
  147. Weber A, Weiss C, Tschernjaew J, Kummel R (1999) Gas antisolvent crystallization. From ­fundamentals to industrial applications. Fraunhofer Institut Umwelt- Sicherheits- Energietechnik,Oberhausen, Germany, pp 235–238Google Scholar
  148. Weber M, Russell LM, Debenedetti PG (2002) Mathematical modeling of nucleation and growth of particles formed by the rapid expansion of a supercritical solution under subsonic conditions. J Supercrit Fluids 23(1):65–80Google Scholar
  149. Werling JO, Debenedetti PG (1999) Numerical modeling of mass transfer in the supercritical antisolvent process. J Supercrit Fluids 16(2):167–181Google Scholar
  150. Werling JO, Debenedetti PG (2000) Numerical modeling of mass transfer in the supercritical antisolvent process: miscible conditions. J Supercrit Fluids 18(1):11–24Google Scholar
  151. Westesen K, Siekmann B (1998) Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof. US 5785976, 12 April 1994Google Scholar
  152. Wubbolts FE, Bruinsma OSL, van Rosmalen GM (1999) Dry-spraying of ascorbic acid or acetaminophen solutions with supercritical carbon dioxide. J Crystal Growth 198/199(Pt. 1):767–772Google Scholar
  153. Xu XM, Song YM, Ping QN, Wang Y, Liu XY (2006) Effect of ionic strength on the temperature-dependent behavior of hydroxypropyl methylcellulose solution and matrix tablet. J Appl Polym Sci 102:4066–4074Google Scholar
  154. Yildiz N, Tuna S, Döker O, Çalimli A (2007) Micronization of salicylic acid and taxol (paclitaxel) by rapid expansion of supercritical fluids (RESS). J Supercrit Fluids 41(3):440–451Google Scholar
  155. Young TJ, Johnston KP, Mishima K, Tanaka H (1999) Encapsulation of lysozyme in a biodegradable polymer by precipitation with a vapor-over-liquid antisolvent. J Pharm Sci 88(6):640–650PubMedGoogle Scholar
  156. Young TJ, Mawson S, Johnston K (2000) Rapid expansion from supercritical to aqueous solution to produce submicron suspensions of water-insoluble drugs. Biotechnol Prog 16:402–407PubMedGoogle Scholar
  157. Young TJ, Johnston KP, Pace GW, Mishra AK (2003) Phospholipid-stabilized nanoparticles of cyclosporine A by rapid expansion from supercritical to aqueous solution. AAPS PharmSciTech 5(1):1–16Google Scholar
  158. Young TJ, Johnston KP, Pace GW, Mishra AK (2004) Phospholipid-stabilized nanoparticles of cyclosporin A by rapid expansion from supercritical to aqueous solution. AAPS PharmSciTech 5(1):70–85Google Scholar
  159. Zhu Z, Anacker JL, Ji S, Hoye TR, Macosko CW, Prud’homme RK (2007) Formation of block copolymer-protected nanoparticles via reactive impingement mixing. Langmuir 23(21):10499–10504PubMedGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2012

Authors and Affiliations

  1. 1.Bristol-Myers SquibbNew BrunswickUSA
  2. 2.Department of Chemical EngineeringThe University of Texas at AustinAustinUSA

Personalised recommendations